The purpose of this report is to describe the specific market segment of the pharmaceutical market of diabetes, metabolic syndrome, and cardiovascular disease. This report reviews and evaluates all of the generally accepted pharmaceutical approaches to diabetes and obesity that are currently used today.

The report is arranged to provide the reader with an overview of the diabetes drug market accompanied by analysis and forecasts by product type and application. Information on the leading diabetes drugs for the treatment of type 1 and 2 diabetes as well as a brief look at the drugs for treating the complications associated with diabetes will be presented in this report.